Thermochromic material, molded article comprising said material and use thereof
US-9193863-B2 · Nov 24, 2015 · US
US10133093B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10133093-B2 |
| Application number | US-201615080312-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 24, 2016 |
| Priority date | Dec 20, 2007 |
| Publication date | Nov 20, 2018 |
| Grant date | Nov 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to doping capsules which have a substance which displays a decreasing transparency with increasing temperature within a defined temperature range due to physicochemical interactions with the polymer matrix to be doped. Likewise, the invention relates to composite systems which have a polymer matrix doped with the doping capsules. The capsules according to the invention are used for sun protection or heat reflection.
Opening claim text (preview).
The invention claimed is: 1. A method for sun protection and/or heat reflection comprising utilizing a composite comprising at least one polymer matrix and doping capsules comprising at least one substance which has a rotator phase in a temperature range of 10 to 55° C., wherein the doping capsules are present in a range of from 0.1 wt. % to 8.5 wt. % of the composite, the capsules displaying a decrease in transparency in the temperature range with increasing temperature wherein the at least one substance is present as a separate phase and in monodisperse form, and the composite has a UV-Vis. NIR or IR wavelength transmission of at least 30%, and, wherein the at least one substance is selected from the group consisting of saturated or unsaturated aliphatic hydrocarbons (C 10 -C 30 ), saturated or unsaturated fatty alcohols and fatty amines, esters of fatty acids and halogenated hydrocarbons, cholesteryl compounds, polyolefins, organometals, and mixture thereof. 2. The method according to claim 1 , wherein the at least one substance has a rotator phase in the temperature range of 15 to 45° C. 3. The method according to claim 1 , wherein a plastic crystalline phase is formed in the temperature range. 4. The method according to claim 1 , wherein the at least one substance is selected from the group of saturated or unsaturated hydrocarbons. 5. The method according to claim 1 , wherein the capsule comprises in addition substances without a rotator phase. 6. The method according to claim 1 , wherein the capsules are microcapsules and have a diameter in the range of 1 to 10 μm. 7. The method according to claim 1 , wherein the capsules are nanocapsules and have a diameter in the range of 10 nm to 1 μm. 8. The method according to claim 1 , wherein the capsules consist of a mixture of microcapsules and nanocapsules. 9. The method according to claim 1 , wherein the at least one substance comprises saturated or unsaturated aliphatic hydrocarbons (C 10 -C 30 ) comprising n-tetradecane, n-eicosane, n-nonadecane, n-heptacosane, hexadecane or any combination thereof. 10. The method according to claim 1 , wherein the at least one substance comprises saturated or unsaturated fatty alcohol and/or fatty amine comprising dodecyl alcohol, decyl alcohol, hexadecyl alcohol, dodecylamine, decylamine, hexadecylamine, or any combination thereof. 11. The method according to claim 1 , wherein the at least one substance comprises esters of fatty acids and/or halogenated hydrocarbon comprising C 14 -C 26 fatty acid esters, C 14 -C 26 hydrocarbons, perfluoroalkanes, or any combination thereof. 12. The method according to claim 1 , wherein the at least one substance comprises cholesteryl compound comprising cholesterol monohydrate, cholesteryl acetate, stigmasterol or any combination thereof. 13. The method according to claim 1 , wherein the at least one substance comprises polyolefin comprising polyethylene, polypropylene, copolymers thereof, or any combination thereof. 14. The method according to claim 1 , wherein the at least one substance comprises organometal comprising octamethyl ferrocene. 15. The method according to claim 1 , wherein the doping capsules are present in a range of from 0.5 wt. % to 2.5 wt. % of the composite. 16. The method according to claim 1 , wherein the composite has a UV-Vis, NIR, or IR wavelength transmission of at least 50%. 17. The method according to claim 1 , wherein the composite has a UV-Vis, NIR, or IR wavelength transmission of at least 70%. 18. The method according to claim 1 , wherein the at least one polymer matrix is selected from the group consisting of thermoplastics, duromers, elastomers, cast resins, lacquers, hydrogels, inorganic polymers, and mixtures thereof. 19. The method according to claim 1 , wherein the at least one polymer matrix is polyethylene.
Making microcapsules or microballoons {(for medical preparations A61K9/50)} · CPC title
Particulate matter [e.g., sphere, flake, etc.] · CPC title
Thermal properties · CPC title
Solid spheres · CPC title
based on thermo-optic effects (G02F1/132 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.